About Those Manufacturing Employment Numbers…



Last month, the Wall Street Journal published a story straightforwardly titled “U.S. Manufacturing Is in Retreat and Trump’s Tariffs Aren’t Helping.” Exhibit A, meant to indicate as self-evident that tariffs are killing U.S. manufacturing and thus failing in their stated purpose: the fact that American “[m]anufacturers shed workers in each of the eight months after Trump unveiled ‘Liberation Day’ tariffs.”

The piece is a classic of the genre. News outlets, elected officials, think tanks, and other assorted members of the D.C. “policy community” keep asking the same question: What about these manufacturing employment numbers? Don’t they mean tariffs aren’t working?

The numbers are true enough. U.S. manufacturing lost 93,000 jobs between March 2025 and February 2026. It is also true that a decline in manufacturing jobs certainly can indicate something seriously amiss. For example, after the United States normalized trade relations with China in 2000, the American manufacturing sector shed three million jobs in three years.

This did indeed portend a sector in crisis. Manufacturing output, measured appropriately, stagnated, a fact that people living in the affected communities did not miss even if economists did. Eventually, manufacturing productivity flatlined and began a long decline, meaning America got worse at making things efficiently. Fair enough, then, to ask whether manufacturing job loss suggests something wrong with American economic policy now as well.

The problem with the argument the WSJ and others are making, however, is that it misunderstands the logic of reindustrialization. The rebuilding of an atrophied American economy is a slow process that must proceed in stages; tariffs are a vital part of a toolkit intended to prompt that slow, staged process. The real question is whether this logic holds in the face of reality. A reasonable evaluator, rather than a partisan polemicist, would therefore ask several questions.

For example: How was the sector performing before these tariffs? How quickly should we expect manufacturing jobs to increase after one year, if this were working? Are there any signs that indicate something positive happening in manufacturing? The answers (which are, in order: even worse; not at all; yes) suggest that the state of manufacturing employment does not undermine the logic of reindustrialization at all. Working through each question in turn helps clarify why.

First up: past jobs numbers. The argument that declining employment after tariffs demonstrates harm to American industry rests on the implied premise that manufacturing jobs were in a better state before. This was manifestly not the case.

As explained by analyst Alan Tonelson, the Bureau of Labor Statistic (BLS)’s annual benchmark revision, released with its January 2026 jobs report, contains a telling story. American manufacturing lost 81,000 jobs in the first 11 months of Trump’s second term—but lost 179,000 jobs in the preceding 11 months. Breitbart economics editor John Carney, in a direct rebuttal to the WSJ’s February story (helpfully titled “Why the Wall Street Journal Missed the Trump Manufacturing Boom”), explains the point: “Manufacturing employment losses during the Trump tariff period were less than half those recorded during the comparable pre-tariff Biden period. The trajectory improved, not deteriorated.”

This improvement happened despite countervailing pressures from the Trump administration’s severe immigration enforcement efforts, which would reasonably be expected to worsen the manufacturing employment situation. Estimates of how much of the unauthorized labor force works in manufacturing vary; a 2025 analysis from the Center for Migration Studies suggests around 11%. The Dallas Fed reports that unauthorized migration has turned net negative since February 2025, and estimates a “net loss of about 49,000 unauthorized immigrant workers in July [2025] alone,” while the Pew Research Center estimates that 1.2 million immigrants (including both those in the U.S. legally and illegally) had left the workforce by July.

As Carney points out, net negative migration also results in new pressures within the workforce still in the United States, as manufacturing employers compete for workers from a smaller labor pool. Manufacturing job loss has slowed even under these conditions.

American manufacturers also want to hire. Monthly job openings in the manufacturing sector spiked by over 100,000 from a low of 389,000 in April 2025 to a high of 495,000 in January 2026. This does not suggest a sector eager to shed its workers. Quite the opposite: the sector is desperate to grow its workforce. Its difficulty in doing so holds many implications for what policymakers could do better when it comes to workforce development and education, among other things. But skyrocketing demand for manufacturing labor, combined with slowing job loss despite significant enforcement pressure on a meaningful part of the manufacturing workforce, does not suggest a sector in freefall.

Share

Second: How quickly should manufacturing jobs be expected to increase? The answer requires thinking in stages. The first step on the reindustrialization road is to create demand and induce investment; tariffs contribute to this effect by raising the cost of reliance on imports relative to investment in domestic industry. Reindustrialization prompted by tariff pressure therefore necessarily entails short-term pain.

Meeting this increased demand requires increased capacity utilization. In the immediate term, we should expect it to be hard for an atrophied manufacturing labor market to swiftly respond to that need. Manufacturers could be expected instead to increase hours (which they are doing) and boost productivity (which they are also doing).

In the longer term, we should expect growth in employment as new investments pay off and new capacity comes online. A revitalized manufacturing sector should be expected to create jobs—but not in the first year. The example of recent industrial policy (another vital tool of reindustrialization) is instructive. The CHIPS and Science Act was enacted in 2022; asking in early 2023 where all the chip-making jobs were would have been nonsensical. Almost four years later, however, one academic study estimates the policy had “national direct employment effects of approximately 15,000-16,000 jobs in the core semiconductor sector and indirect effects of 15,000-30,000 jobs in related sectors.” No one can build (and then man) a factory overnight.

Third and most important: Are there any signs of a manufacturing sector gradually reorienting itself towards increased production? The answer here is encouraging: yes.

The ISM Manufacturing PMI measures growth or contraction in the sector based on surveys of purchase managers; a PMI above 50 indicates growth. After 12 months of sub-50 readings, the manufacturing index hit 52.6 in January 2026 and 52.4 in February. These are the highest readings since August 2022. They did remain negative through 2025, a point much noted by tariff critics, who now seem strangely silent on the potential import of such a positive turn. S&P Global’s U.S. Manufacturing PMI, for its part, was consistently positive in both 2025 and early 2026 after trending negative in 2024, and seems to have therefore been ignored by the pundits.

Furthermore, the industrial production index is at its highest level since 2019, and has been on an upward trend since November 2024. Manufacturing output has been on an upward trend since 2025 as well, versus a downward trend in the preceding years. The counter-trend spike in demand for manufacturing labor indicates a sector eager to grow. The sector is responding to that pressure with a counter-trend spike in productivity. Manufacturing productivity increased 2 points in 2025—the largest annual increase since 2010, as the BLS helpfully highlights in its March 2026 report. This is healthy; increasing pressure to get better at making things is a key element of a sensible reindustrialization agenda.

None of this compares favorably with the shallow argument that tariffs are destroying American manufacturing. They clearly are not. What seems more likely is that, upon discovering that American manufacturing is not in the unambiguous freefall they predicted, critics have cottoned to a bad argument instead.

There are many quite reasonable criticisms to make about the current trade regime’s relationship to manufacturing. Some we at American Compass have made ourselves. One is that tariffs are insufficient on their own to achieve the desired scale of revitalization, and that when imposed without a comprehensive suite of other policy measures (public-private financing for critical industry and real workforce development solutions, to name just two), they create more pain than needed for less upside than intended. Another is that tariffs implemented in a haphazard, opaque, and unpredictable manner make it harder for manufacturers to invest than necessary, thus offsetting some of the potential gains tariff pressures produce. But these criticisms come from within the frame that tariffs can work, as the data is indicating they can.

Those opposed to tariffs in principle, on the other hand, are stuck grasping at any data that might uphold their narrative that tariffs cause nothing but harm. The real irony, of course, is that when a massive and precipitous decline in American manufacturing jobs really did indicate a crisis in the sector, the free trade absolutists were the first to remind the public that economic transformation takes time, and that painful tradeoffs would be worth it in the long run.

They were wrong; their version of the long run was even worse. Here, however, we seem headed in the right direction. And at the very least, the economists who lectured the American people about the wisdom of achieving general equilibrium over multiple generations through free trade, despite the pain along the way, should refrain from judging an alternative policy a failure because a negative job trend didn’t turn positive overnight.

Leave a comment

Free Training

Source link

Kanthal expands US manufacturing footprint with North Carolina service centre to meet electrification demand


Kanthal has strengthened its position in advanced manufacturing with the inauguration of a new service centre in Concord, North Carolina, aimed at scaling production and deployment of high-temperature electric heating technologies.

The investment reflects growing demand from sectors including electronics, glass and steel, where manufacturers are seeking to electrify heat-intensive processes and reduce reliance on fossil fuels. At the centre of this shift is Kanthal’s Globar® silicon carbide heating element technology, which enables industrial heating applications of up to 2,950°F.

By replacing combustion-based systems, these electric heating elements offer manufacturers a pathway to lower emissions, improved energy efficiency and tighter process control, factors that are becoming increasingly critical as industry faces mounting pressure to decarbonise.

According to the Congressional Budget Office, combustion emissions account for 573 million metric tonnes, or 75% of total emissions in the manufacturing sector. Electrification of industrial heat is therefore seen as a key lever in reducing the sector’s carbon footprint.

The Concord facility will play a dual role in both manufacturing and service delivery. In addition to producing a range of heating solutions—including metallic and Fibrothal® elements—the site now supports local supply of Globar® components, which were previously manufactured and shipped exclusively from Kanthal’s production hub in Perth, Scotland.

Robert Stål, President of Kanthal, said the move builds on the company’s long-standing presence in the U.S. market.

“We have served the U.S. market since the 1930s.  We are already supporting our customers from Concord with a broad portfolio, and adding Globar® to the mix allows us to leverage existing infrastructure. The opening of our Concord service center is the next step in strengthening our local presence in the region which is experiencing a surge in advanced manufacturing.”

– Robert Stål, President of Kanthal.

The new centre is part of a broader $11m investment programme, which also includes a significant expansion of the Perth facility. Upgrades there include an additional 19,000 square feet of manufacturing space, new equipment and an optimised production layout. Together, the two sites are expected to increase overall production capacity by around 40%.

Beyond capacity gains, the Concord site introduces new manufacturing flexibility. Enhanced production technologies enable the facility to tailor heating element configurations to specific furnace designs and customer order cycles, improving responsiveness across quoting, production and delivery.

Simon Lile, President of Kanthal’s Heating Systems business unit, said the upgraded operation is designed to align more closely with U.S. customer requirements, reducing lead times and enabling more agile manufacturing support.

The expansion follows Kanthal’s 2022 consolidation of its U.S. operations into the Concord site, creating a centralised, state-of-the-art manufacturing and distribution hub. With the addition of Globar® production capabilities, the facility now serves as a critical node in the company’s global manufacturing network, supporting both regional demand and the broader shift toward electrified industrial processes.

Free Training

Source link

UCB to Invest $2 Billion in Georgia, Establish First U.S. Manufacturing Facility


Georgia seal

ATLANTA – March 24, 2026 – Governor Brian P. Kemp today announced that global biopharmaceutical giant UCB, Inc. is planning a significant investment of $2 billion in Georgia to establish its first U.S. pharmaceutical biologics manufacturing facility. The investment will generate 330 new jobs over the next several years at the Rowen Foundation’s state-of-the-art, 2,000-acre science and learning campus in Gwinnett County.

“When we met with UCB leadership earlier this year in Belgium, we discussed how the Peach State would be the right partner for their visionary plans in the U.S. that will benefit both patients and hardworking Georgians,” said Governor Brian Kemp. “UCB’s announcement is also a significant milestone for our life sciences industry, representing one of the largest investments in state history and establishing both the Rowen facility and Georgia as a true hub of innovation in this field.”

A global biopharmaceutical company based in Belgium, UCB’s North American headquarters are located in Smyrna and currently support more than 400 jobs. UCB’s expertise spans neurology and immunology.

“This decision reflects our confidence in UCB’s long-term growth and our deep-rooted commitment to the United States,” said Jean-Christophe Tellier, CEO of UCB. “By investing in Georgia, where our U.S. headquarters have been based for more than three decades, we are strengthening our biologics manufacturing capabilities, supporting our innovation pipeline, and creating high-quality jobs in a state that offers outstanding talent, a strong manufacturing tradition, and an ecosystem designed for sustainable, long-term success. This project is expected to generate approximately $5 billion in total economic impact, reflecting the broader value it will create for the region and its communities.”

UCB’s new manufacturing footprint will be located at Rowen, serving as an anchor tenant for this 2,000-acre planned community in metro Atlanta designed to foster collaboration, knowledge sharing, and innovation. The cutting-edge campus will use a digital-first approach by leveraging AI, robotics, and automation while also prioritizing efficiency in the use of any natural resources.  

“We are thrilled that UCB has chosen Gwinnett County to advance its global operations and pioneering innovations,” said Chairwoman Nicole Love Hendrickson, Gwinnett County Board of Commissioners. “An investment of this magnitude was exactly what we envisioned when we committed to establishing Rowen as a hub for collaboration and discovery. As one of the most dynamic and diverse counties in the nation, Gwinnett connects UCB to a highly skilled, globally connected talent pool. UCB’s decision to invest here makes clear what industry leaders increasingly recognize: Gwinnett County is a partner in progress, committed to world-class infrastructure, premier services, and quality of life that support continued growth and success.”

“UCB’s decision to locate their new manufacturing operation in Gwinnett County is a testament to the strength of our entire region to support the growth of the life sciences industry,” said Katie Kirkpatrick, President and CEO of the Metro Atlanta Chamber. “UCB’s innovation, talent, and strategic investment show that metro Atlanta is not just a hub for life sciences today, but a place where the breakthroughs of tomorrow are taking shape.”

Project Director EJane Caraway represented the Georgia Department of Economic Development’s (GDEcD) Global Commerce team on this competitive project in partnership with Partnership Gwinnett, Metro Atlanta Chamber, Georgia Quick Start, and Georgia Power.

“For more than a century, UCB has been a leader in biopharmaceutical innovation,” said GDEcD Commissioner Pat Wilson. “Georgia’s growing life sciences ecosystem and collaborative approach to economic development connect companies with world-class partners in research, education, logistics, and infrastructure. Together with our focus on being the Top State for Talent, it’s why innovators like UCB choose Georgia to advance discoveries from R&D to real-world impact.”

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With approximately 9,000 people in approximately 40 countries, the company generated revenue of €7.7 billion in 2025. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news.

Free Training

Source link